Bharat Biotech

Hyderabad, India Founded: 1996 • Age: 30 yrs
Manufacturer of vaccines and bio-therapeutic products

About Bharat Biotech

Bharat Biotech is a Healthcare company based in Hyderabad (India) founded in 1996 by Suchitra Ella and Krishna Ella. Bharat Biotech has raised $13.74 million across 6 funding rounds from investors including International Finance Corporation, Gates Foundation and CEPI. The company has 2,776 employees. Bharat Biotech has completed 1 acquisition, including Chiron Behring India. Its chief executive, as recorded, is Ajayreddy Parakala. Its website bharatbiotech.com draws about 31 thousand monthly visits. Its Indian entity Bharat Biotech International Limited reported revenue of β‚Ή1,630 Cr. Bharat Biotech offers products and services including COVAXIN, ROTAVAC, and Typbar TCV. Its focus areas include Life Sciences, Immunotherapy, Vaccine and Prophylactic.

Company details

Manufacturer of vaccines and bio-therapeutic products. It offers a portfolio of products which includes a broad range of vaccines and therapeutics for Hepatitis B, Polio, Rabies, Typhoid, tetanus, pertussis,, and Haemophilus influenzae type b. It also provide topical medicines for wounds, burns, ulcers, and others.

Recognitions & Rankings of Bharat Biotech

India's Most Valuable Companies 2023 edition · Source: Hurun India
Rank#320
Valuation
₹11,600 Cr
2022 #345 2021 #341
  • Headquarters Hyderabad, India
  • Employees 2,776
  • Founders Suchitra Ella, Krishna Ella
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bharatbiotech.com
  • Social LinkedIn X Facebook
  • Legal Name Bharat Biotech International Limited
  • Date of Incorporation 15 Feb, 1996
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics

Products & Services of Bharat Biotech

Bharat Biotech offers a comprehensive portfolio of products and services, including COVAXIN, ROTAVAC, and Typbar TCV.

COVAXIN
Vaccine

Vaccine for COVID-19 prevention and protection.

ROTAVAC
Vaccine

Rotavirus vaccine for preventing childhood diarrhea.

Typbar TCV
Vaccine

Typhoid conjugate vaccine for long-term immunity.

Funding Insights of Bharat Biotech

Bharat Biotech has successfully raised a total of $13.74M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $13.74M
  • Total Rounds 6
  • Investors Count 5

All 6 funding rounds of Bharat Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2020Grant––
Jun 2015$18.5MGrant––
May 2010$64,322Grant––
Jun 2007$6MPrivate Equity Round–IFC
–
Jun 2006$7.74MPrivate Equity Round–ICICI Venture
–
Jun 2005Private Equity Round–ICICI Venture
–
Valuation history

5 investors in total: 5 institutional.

Investors in Bharat Biotech

Bharat Biotech has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include International Finance Corporation, Gates Foundation and CEPI.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Healthcare investments are targeted by this private equity firm.
2017cepi.netOslo, Norway
IFC is focused on private sector development in emerging markets.
1956ifc.org
Alternative asset management and investment services in India.
1988iciciventure.comMumbai, India
Charitable foundation investments on poverty reduction and healthcare
2000gatesfoundation.orgSeattle, United States
Biotechnology research, guidelines, and funding by the Government of India.
1986dbtindia.gov.inDelhi, India
Premium access

Investor details for Bharat Biotech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Bharat Biotech International Limited (Bharat Biotech)

Bharat Biotech International Limited is the primary company behind Bharat Biotech. The boards of the 2 registered companies of Bharat Biotech currently have 8 directors; the longest-serving is Prathivadibhayankaram Ranganathac Rajagopalan, appointed in 1998. 27 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Prathivadibhayankaram Ranganathac Rajagopalan
DIN 03272757
Director30 Sep 199828 yrs 1 moBharat Biotech International Limited
Suchitra Ella
DIN 00090616
Managing Director25 Sep 200719 yrs 1 moBharat Biotech International Limited
Krishna Mohan Vadrevu
DIN 05222871
Whole-time director28 Dec 201114 yrs 10 moBharat Biotech International Limited
Velagapudi Kavitha Dutt
DIN 00139274
Director20 Mar 20206 yrs 8 moBharat Biotech International Limited
Sai Prasad Devarajulu
DIN 02790648
Whole-time director02 Sep 20206 yrs 2 moBharat Biotech International Limited
Jalachari Ella
DIN 07792035
Designated Partner01 Aug 20224 yrs 3 moSkegen Asset Management Llp
Krishna Murthy Ella
DIN 00072071
Designated Partner01 Aug 20224 yrs 3 moSkegen Asset Management Llp, Bharat Biotech International Limited
Venkateswarlu Jasti
DIN 00278028
Additional Director19 Jan 20269 moBharat Biotech International Limited

People of Bharat Biotech

33 people are tracked at Bharat Biotech (13 in leadership, 20 in team); the tracked headcount is 2,776.

NameRoleGroup
Co-Founder & Managing DirectorLeadership
Co-Founder & Managing DirectorLeadership
Ajayreddy Parakala
CEOLeadership
V Krishna Mohan
Executive DirectorLeadership
T Srinivas
Chief Financial OfficerLeadership
Sumathy K
Head – R&DLeadership
Shareef Mahaboob
Head Of Sales MarketingLeadership
Tadepally Srinivas
Vice PresidentLeadership
Umesh Joshi
Deputy General ManagerLeadership
Srinivas Tadepally
CFOLeadership
Dr.bhargava Ram
Assistant General ManagerLeadership
Sujana Prasad Chittineni
Deputy General ManagerLeadership
Badri Patnaik
Head Clinical DevelopwmntLeadership
Sundaram P A
Deputy ManagerTeam
Pankaj Kumar Patel Patel
Lead - Technical Operationa And Product ServicesTeam
Sridhar Reddy Kaasam
ManagerTeam
Ramesh Rangaiah
Marketing And Business Development ManagerTeam
Fathey Mohammed
Senior Manager HR & AdminTeam
Laxmirajam Bandi
Deputy ManagerTeam
Praveen Jadhav
Production Team MemberTeam

13 more people are available in the full profile.

Premium access

Complete people profiles for Bharat Biotech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Bharat Biotech

Figures of Bharat Biotech International Limited, the primary company behind Bharat Biotech, for FY 2025. Revenue was ₹1,630 Cr (+4% year on year). Net profit was ₹341 Cr (23% margin). EBITDA was ₹609 Cr (42% margin). Revenue has grown at a compounded annual rate of -41% over three years and +9% over five years.

  • ₹1,630 CrRevenue · FY 2025 · +4% YoY
  • ₹341 CrNet profit · 23% margin
  • ₹609 CrEBITDA · 42% margin
  • ₹78.19 CrPaid-up capital
  • 1,286Employees (provident fund records)
  • -41%Revenue CAGR, 3 years
  • +9%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Bharat Biotech International Limited are on its company page.

Premium access

Detailed financial statements for Bharat Biotech

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Bharat Biotech

Bharat Biotech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Chiron Behring India.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Limited information available
chironbehring-india.comAnkleshwar, India0Feb 2019β€’β€’β€’β€’
Premium access

Complete acquisition details for Bharat Biotech

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Bharat Biotech

4 dated milestones of Bharat Biotech across 24 years, from founding to its latest funding, stage changes and deals.

  1. Founded Bharat Biotech is founded.
  2. Funding First funding round.
  3. Acquisition Acquires Chiron Behring India.
  4. Funding Latest funding round, Grant,.

Web traffic of Bharat Biotech

The website of Bharat Biotech (bharatbiotech.com) receives about 30.6K visits a month and ranks #736,609 among all websites worldwide, #844 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    30.6K

    ▲ 8.6% vs previous month

  • Unique visitors
    14.6K

    per month

  • Global rank
    #736,609

    among all websites

  • Category rank
    #844

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Bharat Biotech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bsvgroup.com
100%
7.2K#3,563,176View details
seruminstitute.com
99%
63.5K#656,121View details
ip.mountsinai.org
ip.mountsinai.org
97%
–
virchowbiotech.com
94%
1.4K#4,149,585View details
vical.com
89%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 20 similar websites and full traffic analytics for Bharat Biotech

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 20 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bharat Biotech

Premium access

Complete news archive for Bharat Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bharat Biotech

Bharat Biotech was founded in 1996 and raised its 1st funding round 9 years after it was founded.

Bharat Biotech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Ajayreddy Parakala is the CEO of Bharat Biotech, as recorded in our data.

Bharat Biotech is a funded company, having raised a total of $13.74M across 6 funding rounds to date.

Bharat Biotech has 2,776 employees.

The primary company behind Bharat Biotech, Bharat Biotech International Limited, reported revenue of β‚Ή1,630 Cr for FY 2025, up 4% year on year.

Manufacturer of vaccines and bio-therapeutic products. It offers a portfolio of products which includes a broad range of vaccines and therapeutics for Hepatitis B, Polio, Rabies, Typhoid, tetanus, pertussis,, and Haemophilus influenzae type b. It also provide topical medicines for wounds, burns, ulcers, and others.

Bharat Biotech offers COVAXIN, ROTAVAC, and Typbar TCV.

Bharat Biotech has made 1 acquisition, including Chiron Behring India.

Bharat Biotech has 5 investors. Key investors include International Finance Corporation, Gates Foundation, CEPI, ICICI Venture, and Department of Biotechnology.

Bharat Biotech is associated with 2 legal entities: Bharat Biotech International Limited, Skegen Asset Management Llp.

The legal entities of Bharat Biotech currently have 10 directors, including Jalachari Ella, Krishna Murthy Ella, Krishna Mohan Vadrevu and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available